Introduction {#s1}
============

Infection with species of the kinetoplastid parasite, *Leishmania*, results in a spectrum of diseases in man, termed the leishmaniases [@pntd.0000476-Murray1],[@pntd.0000476-Peacock1]. These range from the non-fatal chronic cutaneous lesions arising from *L. major* infection to mucocutaneous leishmaniasis usually associated with *L. braziliensis* (classified within the sub-genus *L. Viannia*) and the often fatal visceralising disease, most commonly associated with *L. donovani* infection in the Indian sub-continent, *L. chagasi* in Brazil and *L. infantum* in the Mediterranean basin. (The last two species are generally considered to be genetically identical [@pntd.0000476-Mauricio1]). While the species of infecting parasite can play a defining role in disease type, the genetic background and immune response of the host are also major factors in determining clinical outcome [@pntd.0000476-Guerbouj1],[@pntd.0000476-McMahonPratt1],[@pntd.0000476-Wilson1],[@pntd.0000476-BenSaid1],[@pntd.0000476-Lipoldova1],[@pntd.0000476-Smith1]. Understanding the relative contribution of these different components may enhance our understanding of pathogenicity in the leishmaniases.

Sequencing and comparison of the genomes of representative lab-adapted strains of *L. major*, *L. infantum* and *L. braziliensis* have revealed strong conservation of gene content and synteny, with only a small number of genes identified as differentially distributed between species [@pntd.0000476-Murray1],[@pntd.0000476-Ivens1]. This subset of genes, together with sequences preferentially expressed in intracellular amastigotes and/or showing differential expression between species, may be important in facilitating parasite survival and maintenance within the host. The best-characterised example of the former class is the *L. donovani* complex-specific A2 gene coding for an amastigote protein of as yet unknown function which, when expressed in *L. major*, leads to increased parasite dissemination to the viscera [@pntd.0000476-Zhang1].

Recent expression profiling has identified 3--9% of genes that are modulated at the RNA level between life cycle stages of several *Leishmania* species [@pntd.0000476-Holzer1],[@pntd.0000476-Leifso1],[@pntd.0000476-Rochette1],[@pntd.0000476-Saxena1]. Moreover, comparisons of *L. mexicana* amastigote parasites grown axenically with those maintained within macrophages, either *in vitro* or *in vivo*, have shown that axenic (extracellular) amastigotes are more similar to extracellular promastigotes than to macrophage-derived (intracellular) amastigotes in their RNA profiles [@pntd.0000476-Holzer1]. These observations emphasise the importance of using parasites isolated *ex vivo* to investigate the mechanisms of intracellular survival. To date, no comparative expression profiling has been performed on *L. Viannia spp.*, despite the relative divergence of the genome of *L. braziliensis* from that of *L. major* or *L. infantum* [@pntd.0000476-Murray1].

A complicating factor in the analysis of *Leishmania* gene expression is the almost complete absence of defined RNA polymerase II promotors in kinetoplastid species, coupled with the characteristic bidirectional polycistronic transcription units found on individual chromosomes [@pntd.0000476-ElSayed1],[@pntd.0000476-Clayton1],[@pntd.0000476-Haile1]. In these organisms, polycistronic precursor RNAs (which may be expressed constitutively) are processed by coupled *trans*-splicing and polyadenylation [@pntd.0000476-Liang1] to generate mature mRNA transcripts for translation. Expression of individual genes is regulated post-transcriptionally, a process largely dependent on RNA stabilisation mechanisms [@pntd.0000476-Clayton1],[@pntd.0000476-Haile1]. This post-transcriptional regulation, coupled with an as yet unknown extent of regulation at the level of translation, results in variable correlations between gene and protein expression levels [@pntd.0000476-CohenFreue1],[@pntd.0000476-McNicoll1]. Such factors place greater emphasis on identifying those genes which undergo regulation during the life cycle while also looking for differences in the relative levels of expression of conserved genes.

Given the importance of intracellular *Leishmania* stages to disease in man, this study has focused on amastigote gene expression, comparing RNA expression profiles between the three sequenced *Leishmania* species to identify any significant differences that may be functionally relevant in these infective parasite stages. To achieve this end, an oligonucleotide array was designed representative of 4 functional classes of genes, together comprising ∼10% of the genome. These targets included (i) all genes identified as differentially-distributed between the 3 sequenced *Leishmania* species [@pntd.0000476-Murray1]; (ii) all genes containing amino acid repeats within their open reading frames [@pntd.0000476-Depledge1]; (iii) all genes encoding proteins predicted (with high probability) to be co-translationally modified by *N*-myristoylation [@pntd.0000476-Mills1]; (iv) a range of control genes of known RNA expression profiles.

The rationale for this choice of target genes is that their expressed products provide a subset for analysis as putative targets for therapeutic intervention. 2--4% of the 3 sequenced *Leishmania* genomes, including 30% of the differentially-distributed genes, contain amino acid repeats within their protein-coding regions, as identified by the RepSeq web utility [@pntd.0000476-Depledge1]. Repeat domains are associated with a range of functions relevant to host survival in other protozoan parasites, including antigenic variation, host-cell receptor binding and intracellular protein-protein interactions in *Plasmodium* species [@pntd.0000476-Rosenthal1],[@pntd.0000476-Tetteh1],[@pntd.0000476-Scherf1]. Amino acid repeat-containing proteins encoded within the *Leishmania* genomes include several kinases, cysteine peptidases, putative surface antigen proteins and the infective stage-specific HASPB (formerly named GBP), expressed in amastigotes of all *L. Leishmania* species analysed but absent from *L.(Viannia.) braziliensis* [@pntd.0000476-Murray1],[@pntd.0000476-Alce1],[@pntd.0000476-McKean1],[@pntd.0000476-Nugent1],[@pntd.0000476-Rangarajan1]. HASPB is also a target for *N*-myristoylation, a co-translational protein modification catalysed by the enzyme *N*-myristoyltransferase (NMT) that is a genetically-validated target for *Leishmania* drug development [@pntd.0000476-Price1],[@pntd.0000476-Gelb1].

Hybridisation of these customised oligonucleotide arrays with amastigote RNA derived from footpad lesions (*L. major*), spleens (*L. infantum*) and RAW 264.7 macrophages (*L. braziliensis*) revealed that only a small number of the target genes are differentially expressed at the mRNA level between species and that fewer still are regulated during the parasite life cycle. In addition, comparison of expression profiles derived from *L. major* amastigotes isolated from hosts of differing immune competence (BALB/c vs. Rag2^−/−^ γ~c~ ^−/−^ mice [@pntd.0000476-Goldman1]) demonstrated that host immune pressure has little effect on parasite gene expression at the RNA level. Taken as a whole, the data presented here suggest that parasites do not respond dynamically to host immune pressure and that any influence of varying transcript levels on virulence and pathogenicity of different *Leishmania* species is likely to result from the differential expression of conserved genes between species and/or the expression of a small number of genes that are differentially distributed between species.

Materials and Methods {#s2}
=====================

In silico analyses {#s2a}
------------------

The three representative *Leishmania* proteomes (*L .major*, *L. braziliensis* and *L. infantum*) were analysed for the presence of amino acid repeats using default settings at the RepSeq web utility ([www.repseq.org](http://www.repseq.org); [@pntd.0000476-Depledge1]); 256 proteins were identified. A further 62 proteins were predicted to be *N*-terminally myristoylated with high confidence using the NMT Predictor and Myristoylator programs as described [@pntd.0000476-Mills1]. The genes identified as differentially distributed between the three *Leishmania* species [@pntd.0000476-Murray1] were reanalysed using BLAST and the latest assemblies of the three genomes available at the time on GeneDB (*L. major* published assembly [@pntd.0000476-Ivens1], *L. infantum* v2 and *L. braziliensis* v1). 242 of these genes were included in this study ([Table S1](#pntd.0000476.s001){ref-type="supplementary-material"}); the remainder have been removed during annotation revision.

Leishmania culture, differentiation and in vivo infections {#s2b}
----------------------------------------------------------

The three sequenced genome reference strains used were *L. major* MHOM/IL/80/Friedlin; *L. infantum* clone JPCM5 MCAN/ES/98/LLM-877; *L. braziliensis* clone M2904 MHOM/BR/75M2904. Procyclic and metacyclic parasites were maintained at 26°C in pH 7.0 and pH 5.5 media respectively; for *L. major* and *L. braziliensis*, 1×M199 medium was supplemented with 10% Gibco fetal bovine serum (FBS, Invitrogen) and penicillin-streptomycin (Invitrogen) and, in the case of *L. braziliensis*, 2% human male urine. *L. infantum* was cultured in Gibco HOMEM (Invitrogen) supplemented with 10% FBS (Biosera) and penicillin-streptomycin. The pH of all media was adjusted using orthophosphoric acid. Metacyclic RNAs were validated by RT-qPCR profiling of the metacyclic specific markers SHERP [@pntd.0000476-Knuepfer1] in *L. major* and *L. infantum* and Meta1 [@pntd.0000476-Gamboa1] in *L. braziliensis*. For *L. major in vivo* passage, BALB/c and Rag2^−/−^γ~c~ ^−/−^ mice [@pntd.0000476-Goldman1],[@pntd.0000476-Mazurier1] were infected sub-cutaneously in the rear footpad with 4×10^6^ late stage *L. major* metacyclics purified by Percoll gradient fractionation [@pntd.0000476-Ahmed1]. Footpad thickness was measured weekly using digital calipers, taking an average of three readings. At four weeks post-infection, mice were euthanized and tissues were sampled for analysis. For *L. infantum in vivo* passage, infection was initiated in hamsters by intraperitoneal inoculation of 10^7^ stationary phase metacyclics as described [@pntd.0000476-Denise1], with euthanasia and spleen removal 9--12 months later.

BALB/c mice (Charles River Laboratories) and Rag2^−/−^γ~c~ ^−/−^ mice (bred in the Centre for Immunology and Infection) were housed in pathogen-free conditions at the University of York. All animal work was conducted under UK Home Office Licence requirements and after institutional ethical review. Attempts to purify amastigotes from the footpads of BALB/c, C57BL/6 and Rag2^−/−^γ~c~ ^−/−^ mice infected with the *L. braziliensis* genome strain were unsuccessful (despite establishment of lymph nodes infections with the same parasites), so Percoll-purified metacyclics were used to infect RAW 264.7 macrophages maintained in DMEM medium supplemented with 10% FBS, l-glutamine and sodium pyruvate (1 mM final concentrations). Amastigotes were obtained from infected macrophages after 3 days culture at 34°C. For all species, infections were initiated with parasites that had been recently passaged *in vivo* to reduce any impact of long term *in vitro* culture on parasite gene expression and virulence.

Amastigote isolation and protein analysis {#s2c}
-----------------------------------------

Infected tissues were homogenised and fractionated (centrifugation at 100 g, 4°C) to remove larger debris. Host cells in the resulting supernatant were pelleted (2000 g, 4°C) and treated with 0.05% w/v saponin (Sigma Aldrich) for lysis and release of amastigotes. Host cell debris was removed by layering parasites over Percoll (1.037 g/ml) and centrifugation at 2000 g, 4°C for 1 hr. Amastigote yields were assessed using a haemocytometer and Beckman Z Series Coulter Counter. Parasite species was verified by restriction fragment length polymorphism analysis of amastigote DNA [@pntd.0000476-Schonian1].

For immunoblotting, 5×10^6^ host-derived amastigotes were pelleted, washed in PBS and resuspended in an SDS load mix supplemented with Pepstatin A (50 ug/ml). Treatment with 3% β-mercaptoethanol was followed by a 10 min incubation at 95°C prior to 12% SDS-PAGE, electroblotting on immobilon-P membrane (Millipore) and probing with anti-HASPB [@pntd.0000476-Flinn1],[@pntd.0000476-Denny1] at 1∶1250 dilution and anti-NMT [@pntd.0000476-Price1] at 1∶1000, as previously described. ECL Western Blotting Detection Reagents (GE Healthcare Lifesciences) were used in conjunction with a G∶BOX Chemi Imaging System and GeneSnap V.7.0 software (Syngene) to determine relative expression of detected proteins.

Analysis of parasite burdens {#s2d}
----------------------------

*L. major* parasite burdens in mouse footpad lesions were determined by purification and manual counting while those in the liver and spleen tissues were assessed from duplicate samples using quantitative PCR, adapted from the method of [@pntd.0000476-Nicolas1]. DNA was extracted from tissues using a DNeasy Blood and Tissue kit (Qiagen) following overnight digestion with Proteinase K at 55°C. Quantitation of *L. major* DNA was performed using primers specific for a 116-bp fragment of the kinetoplastid minicircle DNA: forward, 5′-CCTATTTTACACCAACCCCCAGT-3′(JW11) and reverse, 5′-GGGTAGGGGCGTTCTGCGAAA-3′ (JW12) [@pntd.0000476-Nicolas2]. DNA standards were created for each tissue sampled, by spiking naïve tissue with known numbers of *L. major* promastigotes and extracting the DNA as described above. For RT-qPCR reactions, samples were analysed using Power SYBR Green PCR Master Mix and an ABI 7300 sequence analyzer (Applied Biosystems). Samples were subjected to an initial holding step at 95°C for 10 min, followed by an amplification step (40 cycles of 95°C for 15 sec and 60°C for 1 min) and a single dissociation step of 95°C for 15 sec, 60°C for 20 sec and 95°C for 15 sec. The total parasite burden per organ was calculated by determining the total number of parasites per g of tissue sampled and multiplying by total organ mass.

RNA isolation, cDNA synthesis and labelling {#s2e}
-------------------------------------------

Amastigote pellets were resuspended in TRIzol Reagent (Invitrogen) at a concentration of 1 ml/10^8^ cells and total RNA extracted using the protocol provided. Extracted RNA was purified using a MEGAclear kit (Ambion) and the quantity and quality verified using a NanoDrop ND-1000 Spectrophotometer and Agilent 2100 Bioanalyzer, respectively, prior to storage at −80°C. cDNA synthesis and subsequent labelling was performed using the Amino Allyl cDNA labeling kit (Ambion) and Alexa Flour 555 and 647 dyes (Invitrogen).

DNA oligonucleotide array design, slide printing, washing and pre-hybridisation {#s2f}
-------------------------------------------------------------------------------

70-mer oligonucleotides were designed and synthesised by Operon Biotechnologies using parameters such that a single oligo had \>90% identity with the gene target in each of the three species but \<70% identity with any other gene on the array. All oligos ([Table S2](#pntd.0000476.s002){ref-type="supplementary-material"}) were BLAST-searched against the NCBI databases for the mouse and hamster genomes, to minimise potential cross hybridisation. The microarrays were printed on Nexterion Slides E (Schott) using a QArrayMini (Genetix) as follows: 5 replicates were printed for each probe in a random pattern totalling 5376 probes per slide (including buffer and negative controls). cDNA from procyclic RNA from each of the three species was hybridised against the arrays for quality control, revealing that all probes were hybridised (data not shown). Prior to hybridisation, each slide was washed at room temperature as follows: 1×5 min in 0.1% Triton X-100, 2×2 min in 1 mM HCL, 1×10 min in 100 mM KCL. Slides were subsequently blocked by incubation in 1×Nexterion Blocking E (Schott) for 15 min and then dried by centrifugation.

Microarray hybridisation and signal detection {#s2g}
---------------------------------------------

Labelled cDNA pellets were resuspended in Nexterion Hyb and hybridised on the slides in Corning hybridisation chambers (Fisher) for 16 hrs at 45°C. The slides were then washed in 2×Sodium Chloride Citrate (SSC)/0.1% sodium dodecyl sulphate (SDS) for 5 min, 2×SSC for a further 5 min, 0.2×SSC for 5 min and dried by centrifugation at 200 g for 3 min. The slides were scanned using an Axon 4000A scanner and fluorescence signal intensities of the array features and local backgrounds measured by GenePix Pro 5.0.

Data processing and statistical analysis {#s2h}
----------------------------------------

For each slide, flags were automatically assigned to each probe and manually evaluated, based on the quality of hybridisation, to assist in normalisation within and between arrays. All raw data extracted from GenePix were imported into R 2.2.1 for normalization and statistical analysis using the Bioconductor packages ([www.bioconductor.org](http://www.bioconductor.org)), predominantly Limma. Briefly, gpr files were read and background correction performed using the Kooperberg model. QC analysis, entailing density distribution analysis coupled with correlation distance heatmap plotting, was used to identify substandard arrays, which were removed from further analysis. Array data were normalised within arrays using printtiploess, followed by normalisation between arrays using the "Aquantile" method, which normalises intensity distribution across all slides. Subsequently, the mean intensity was determined for the 5 replicate spots on each array prior to single channel linear modelling and contrast fitting of non-control array features, with eBayes methods to generate moderated t-statistics. Four contrasts were performed: *L. braziliensis* procyclics vs. metacyclics vs. amastigotes, *L. major* amastigotes vs. procyclics, *L. infantum* amastigotes vs. procyclics and *L. major* amastigotes from BALB/c mice vs. *L. major* amastigotes from Rag2^−/−^γ~c~ ^−/−^ mice.

Gene lists were generated, with accompanying statistics, from the eBayes fit data. The decideTests method was applied, with an adjust p value threshold of 0.01, to classify genes as to their significance in one of more contrasts. A fold change of 1.7 was then used as threshold for determining differentially expressed genes, similar to other recent studies [@pntd.0000476-Leifso1],[@pntd.0000476-Rochette1],[@pntd.0000476-CohenFreue1]. In accordance with MIAME (Minimum Information About a Microarray Experiments) regulations [@pntd.0000476-Brazma1], all data were deposited into ArrayExpress database [@pntd.0000476-Parkinson1] at [www.ebi.ac.uk](http://www.ebi.ac.uk) under the accession number E-MEXP-2063.

For host-derived amastigote analysis, a minimum of 3 biological replicates (each comprising 2--3 technical replicates) per species were used. 2--3 technical replicates were also used for each of the following analyses: culture-derived amastigotes, metacyclics and procyclics

Quantitative real-time PCR (RT-qPCR) {#s2i}
------------------------------------

RT-qPCR was performed on selected genes to validate the microarray data, using 1--2 biological replicates (independent of those used on the arrays). cDNA was synthesised using the Omniscript RT Kit (Qiagen) . Cross-species primers were designed by aligning gene sequences using CLUSTALW (<http://align.genome.jp/>) and then selecting primers based on the output of Primaclade [@pntd.0000476-Gadberry1]. Each biological sample was run with 4--5 technical replicates. Data generated were analysed [@pntd.0000476-Pfaffl1] and normalised using a range of suitable targets (including published controls; [@pntd.0000476-Rochette1],[@pntd.0000476-Gamboa1],[@pntd.0000476-Ouakad1]). All primers used are shown in [Table S3](#pntd.0000476.s003){ref-type="supplementary-material"}.

Results/Discussion {#s3}
==================

Previous expression profiling studies, using arrays of varying size and composition, have revealed that the transcriptomes of four *L. Leishmania* species (*L. major*, *L. infantum*, *L. donovani and L mexicana*; [@pntd.0000476-Holzer1],[@pntd.0000476-Leifso1],[@pntd.0000476-Rochette1],[@pntd.0000476-Saxena1],[@pntd.0000476-Akopyants1],[@pntd.0000476-Almeida1],[@pntd.0000476-Saxena2]) are largely expressed at constitutive levels during the parasite life cycle, with only a limited number of genes (\<10% of the genome) showing significant evidence of regulation (fold change \>1.7, p\<0.05) at the mRNA level. No data have yet been presented on global expression profiles of any *L. Viannia spp*, nor has there been an investigation into the potential influence of immune pressure on parasite gene expression in the host.

The custom microarrays used in this study targeted 785 genes representing ∼10% of the genome of the 3 target *Leishmania* species, *L. major*, *L. infantum* and *L. braziliensis*. Following hybridisation, a total of 46 genes were selected from the arrays for validation of their RNA expression profiles by RT-qPCR. These included a number of previously-characterised stage-regulated and constitutively-expressed genes across all three species. In total, 74% (17/23) of the *L. braziliensis* genes tested for their expression across the parasite life cycle showed good correlation between RNA levels detected by RT-qPCR and microarray analysis ([Table 1](#pntd-0000476-t001){ref-type="table"}). A further 8 out of 9 targets from the cross-species comparison and 12 out of 14 targets selected from the study of host immune pressure on *L. major* gene expression were also validated by comparison of RT-qPCR and microarray data ([Table 1](#pntd-0000476-t001){ref-type="table"}). In most cases, the observed fold changes were comparable between the microarray and RT-qPCR data although in some instances, larger differences between the two methods of analysis were measured. This trend has been reported in similar studies [@pntd.0000476-Holzer1],[@pntd.0000476-Rochette1] and is likely to be due to the increased sensitivity and specificity of RT-qPCR against single gene targets.

10.1371/journal.pntd.0000476.t001

###### Validation of microarray data by quantitative RT-PCR (RT-qPCR).

![](pntd.0000476.t001){#pntd-0000476-t001-1}

  *L. braziliensis* lifecycle    *L. braziliensis* vs *L. infantum* amastigotes                                                                                                                                                                                       
  ----------------------------- ------------------------------------------------ ---------------------------------------- ------------------------------------------------------------------------ -------------------------- --------------------------------------- ---------------------------------------
  LbrM04_V2.0370                                      2.78                        −1.45[\*](#nt101){ref-type="table-fn"}                               LbrM03_V2.0240                                    LinJ03_V3.0220                        −5.82                                   −0.83
  LbrM07_V2.0360                                     −1.11                                        −1.22                                                LbrM08_V2.0810                                    LinJ08_V3.0960                        2.22                                    5.34
  LbrM09_V2.0960                                     −1.04                                        −2.94                                                LbrM16_V2.0920                                    LinJ16_V30920                         2.53                                   291.62
  LbrM11_V2.0560                                     −2.80                                        −1.63                                                                                                                                                               
  LbrM12_V2.0750                                     −2.31                                        −0.84                                   ***L. major*** **vs** ***L. infantum***                                                                                     
  LbrM21_V2.0360                                      2.51                        0.55[\*](#nt101){ref-type="table-fn"}                            ***L. major*** **ID**                            ***L. infantum*** **ID**              **Array LogFC**                        **RT-qPCR LogFC**
  LbrM26_V2.0120                                      0.84                                         1.64                                                 LmjF03.0230                                      LinJ03_V3.0220                        −5.29                                  −10.43
  LbrM31_V2.2570                                     −0.89                                        −2.90                                                 LmjF13.0880                                      LinJ13_V3.0770                        −2.68                                   −2.66
  LbrM31_V2.3150                                      1.91                        −1.09[\*](#nt101){ref-type="table-fn"}                                LmjF29.1480                                      LinJ29_V3.1580                        0.01                    9.49[\*](#nt101){ref-type="table-fn"}
  LbrM34_V2.4130                                     −3.15                                        −2.71                                                 LmjF31.3000                                      LinJ31_V3.3110                        −1.83                                   −1.87
  LbrM08_V2.0810                                      1.95                        −0.57[\*](#nt101){ref-type="table-fn"}                                LmjF32.1950                                      LinJ32_V3.2060                        0.01                                    1.21
  LbrM09_V2.0840                                      1.19                                         2.54                                                 LmjF36.4310                                      LinJ36_V3.4520                        2.88                                    0.28
  LbrM09_V2.0960                                     −0.82                                        −0.46                                                                                                                                                               
  LbrM11_V2.0560                                     −2.51                                        −0.18                    ***L. major*** **amastigotes from BALB/c and Rag2^−/−^γ~c~^−/−^ mice**                                                                     
  LbrM20_V2.0550                                      2.48                                         1.01                                            ***L. major*** **ID**                                **Array LogFC**                  **RT-qPCR LogFC**            
  LbrM31_V2.3150                                      2.08                        −1.84[\*](#nt101){ref-type="table-fn"}                                LmjF03.0230                                           0.50                             0.05                   
  LbrM04_V2.0370                                     −3.67                        2.55[\*](#nt101){ref-type="table-fn"}                                 LmjF04.0210                                          −0.17             0.44[\*](#nt101){ref-type="table-fn"}  
  LbrM08_V2.0810                                      1.67                                         1.09                                                 LmjF24.0220                                          −0.25                             −0.12                  
  LbrM12_V2.0750                                      3.08                                         4.16                                                 LmjF24.1840                                           1.35                             0.43                   
  LbrM18_V2.0050                                      1.62                        −1.07[\*](#nt101){ref-type="table-fn"}                                LmjF25.1820                                          −0.03                             −0.18                  
  LbrM20_V2.0550                                      2.46                                         1.99                                                                                                                                                               
  LbrM32_V2.2500                                      0.79                                         3.66                                                                                                                                                               
  LbrM34_V2.4130                                      3.47                                         1.41                                                                                                                                                               

**\*:** **RT**-qPCR data does not validate microarray data; LogFC represents −log~2~(fold change); ID, each ID refers to the GeneDB gene entry.

Only a small number of the genes analysed are regulated in their expression during the *L. braziliensis* lifecycle {#s3a}
------------------------------------------------------------------------------------------------------------------

Expression profiles were generated for each *L. braziliensis* life cycle stage using mRNA from culture-derived procyclics and metacyclics and RAW 264.7 macrophage-derived amastigotes. The profiles were analysed using scatter plots ([Figure 1A--C](#pntd-0000476-g001){ref-type="fig"}), revealing that ∼9% (60/678) of the genes probed were significantly regulated (fold change \>1.7, p-value\<0.05) in their expression between life cycle stages. Thus, although the arrays used for this analysis of *L. braziliensis* gene expression represent only 10% of the genome (and are biased towards specific gene subsets), the proportion of stage-regulated genes (∼9%) is of the same order of magnitude as that observed in whole genome analysis of *L. major* (7%), *L. mexicana* (3.5%) and *L. infantum* (9.3%) [@pntd.0000476-Holzer1],[@pntd.0000476-Rochette1].

![Expression profiling of gene subsets from three *Leishmania* genomes.\
Scatter plots (generated using Microsoft Excel) show the distribution of log~2~ fold changes in RNA expression levels against their statistical significance (−log~2~ p-value) for up to 785 genes per genome. Fold change of \>1.7 between data points (dashed horizontal lines); significant p-value\<0.05 (dashed vertical lines). (A) *L. braziliensis* amastigotes vs. procyclics; (B) *L. braziliensis* amastigotes vs. metacyclics; (C) *L. braziliensis* metacyclics vs. procyclics; amastigotes of (D) *L. braziliensis* vs. *L. major*, (E) *L. braziliensis* vs. *L. infantum*, (F) *L. major* vs. *L. infantum*; (G) *L. major* amastigotes from BALB/c vs. Rag2^−/−^γ~c~ ^−/−^ mice.](pntd.0000476.g001){#pntd-0000476-g001}

Of the 60 regulated genes in *L. braziliensis* ([Table 2](#pntd-0000476-t002){ref-type="table"}, [Figure 2](#pntd-0000476-g002){ref-type="fig"}), 5 were preferentially expressed in amastigotes (LbrM05_V2.0380 - microtubule-associated protein, LbrM07_V2.0360 - ATP-dependent DEAD/H RNA helicase, LbrM09_V2.0960 - calmodulin, LbrM11_V2.0560 - 40S ribosomal protein S21 and LbrM31_V2.2570 - 3′ nucleotidase/nuclease) with a further 35 preferentially expressed in metacyclics and 11 in procyclics. Analysis of the specific gene subsets identified none of the NMT targets as upregulated in amastigotes while 5 of these genes showed preferential expression in either procyclics and/or metacyclics. 9.8% (25/256) of the genes coding for proteins containing amino acid repeats showed stage specific regulation, with 3 of these encoding proteins of unknown function that are preferentially expressed in the procyclic and metacyclic stages (as compared with amastigotes). Interestingly, all of the genes preferentially expressed in *L. braziliensis* amastigotes in this analysis, with the exception of the calmodulin array, contain repeat motifs. If these RNA differences correlate with protein levels, this result could indicate that repeat-containing proteins are functionally important in the intracellular stage of the life cycle and provide a useful sub-set of biomarkers with diagnostic and vaccination potential.

![Distribution of genes preferentially expressed in one or more stages of *L. braziliensis*.\
Venn diagram showing distribution of upregulated genes (\>1.7 fold, p\<0.05) in stages of the *L. braziliensis* life cycle. 8.8% (60/678) of the genes probed are regulated in their expression by these criteria, with 58% of these showing increased expression during the metacyclic stage. \*Genes that are not differentially expressed between these stages.](pntd.0000476.g002){#pntd-0000476-g002}

10.1371/journal.pntd.0000476.t002

###### Genes differentially expressed during the *L. braziliensis* lifecycle.

![](pntd.0000476.t002){#pntd-0000476-t002-2}

  *L. braziliensis*: Amastigotes vs. Procyclics                                                                  
  ------------------------------------------------ ------------------------------------ ------- -------- ------- ------------
  LbrM34_V2.4130                                          Poly A binding protein         −3.15   0.0197   SRR\*   Amastigote
                                                        40S ribosomal protein S21        −2.80   0.0359   SRR\*   Amastigote
  LbrM12_V2.0750                                    Surface antigen proteins (1 and 2)   −2.31   0.0008   SRR\*   Amastigote
  LbrM07_V2.0360                                    ATP-dependent DEAD/H RNA helicase    −1.11   0.0405   SRR\*   Amastigote
  LbrM09_V2.0960/LbrM09_V2.0970/LbrM09_V2.0980                  Calmodulin               −1.04   0.0274    \*     Amastigote
  LbrM31_V2.2570[§](#nt103){ref-type="table-fn"}         3′ nucleotidase/nuclease        −0.89   0.0272    \*     Amastigote
  LbrM26_V2.0120                                    Adenine phosphoribosyltransferase    0.84    0.0050    \*     Procyclic
  LbrM22_V2.1410[§](#nt103){ref-type="table-fn"}             Unknown function            0.86    0.0398           Procyclic
  LbrM27_V2.1350[§](#nt103){ref-type="table-fn"}             Carboxypeptidase            0.99    0.0172           Procyclic
  LbrM33_V2.0190                                             Unknown function            1.08    0.0397           Procyclic
  LbrM11_V2.0160                                             Unknown function            1.08    0.0163           Procyclic
  LbrM20_V2.4280                                             Unknown function            1.11    0.0062           Procyclic
  LbrM12_V2.0750                                    Surface antigen proteins (1 and 2)   1.20    0.0006    SRR    Procyclic
  LbrM34_V2.0500                                             Unknown function            1.84    0.0000           Procyclic
  LbrM31_V2.3150                                         Adp-ribosylation factor         1.91    0.0073   NMT\*   Procyclic
  LbrM21_V2.0360                                             Unknown function            2.51    0.0126   NMT\*   Procyclic
  LbrM04_V2.0370                                         Adp-ribosylation factor         2.78    0.0425   NMT\*   Procyclic
  LbrM30_V2.1290                                             Unknown function            3.98    0.0008           Procyclic
  LbrM31_V2.0450                                             Unknown function            4.25    0.0035           Procyclic

  *L. braziliensis*: Amastigotes vs. Metacyclics                                                                                
  ------------------------------------------------------------- -------------------------------------- ------- -------- ------- ------------
  LbrM11_V2.0560                                                      40S ribosomal protein S21         −2.51   0.0034   SRR\*   Amastigote
  LbrM12_V2.0750^§§^                                              Surface antigen proteins (1 and 2)    −2.08   0.0215    SRR    Amastigote
  LbrM05_V2.0380                                                    Microtubule-associated protein      −1.11   0.0454           Amastigote
  LbrM09_V2.0960/LbrM09_V2.0970/LbrM09_V2.0980                                Calmodulin                −0.82   0.0063    \*     Amastigote
  LbrM34_V2.0360                                                     Serine palmitoyltransferase        0.82    0.0184           Metacyclic
  LbrM04_V2.1260                                                     Surface antigen-like protein       0.86    0.0252    SRR    Metacyclic
  LbrM27_V2.1350[§](#nt103){ref-type="table-fn"}                           Carboxypeptidase             0.86    0.0014           Metacyclic
  LbrM33_V2.0190                                                           Unknown function             0.90    0.0071           Metacyclic
  LbrM19_V2.1010                                                               Kinesin                  0.91    0.0001    SRR    Metacyclic
  LbrM35_V2.5860                                                       G-actin binding protein          0.91    0.0269           Metacyclic
  LbrM11_V2.0160                                                           Unknown function             0.96    0.0010           Metacyclic
  LbrM08_V2.1090/LbrM08_V2.1080/LbrM08_V2.1100                           Amastin-like protein           0.98    0.0033           Metacyclic
  LbrM34_V2.5330                                                           Unknown function             0.99    0.0107           Metacyclic
  LbrM07_V2.0890                                                           Unknown function             1.11    0.0253           Metacyclic
  LbrM20_V2.4280                                                           Unknown function             1.11    0.0000           Metacyclic
  LbrM33_V2.1190                                                           Unknown function             1.17    0.0037           Metacyclic
  LbrM24_V2.1790                                                            Protein kinase              1.18    0.0068    NMT    Metacyclic
  LbrM04_V2.0590                                                           Unknown function             1.18    0.0075           Metacyclic
  LbrM09_V2.0840                                                           Unknown function             1.19    0.0005   SRR\*   Metacyclic
  LbrM06_V2.0760                                                     RNA-binding protein-like pr        1.20    0.0016    SRR    Metacyclic
  LbrM25_V2.0950                                                           Unknown function             1.28    0.0035    SRR    Metacyclic
  LbrM22_V2.1410[§](#nt103){ref-type="table-fn"}                           Unknown function             1.30    0.0000           Metacyclic
  LbrM07_V2.0550                                                           Unknown function             1.30    0.0006           Metacyclic
  LbrM28_V2.3180[§](#nt103){ref-type="table-fn"}                           Unknown function             1.32    0.0224           Metacyclic
  LbrM32_V2.1080                                                           Unknown function             1.39    0.0250           Metacyclic
  LbrM24_V2.0360/LbrM24_V2.0440                                      CMP-sialic acid transporter        1.40    0.0291           Metacyclic
  LbrM33_V2.3400                                                           Unknown function             1.44    0.0252           Metacyclic
  LbrM23_V2.0100                                                           Unknown function             1.50    0.0472    SRR    Metacyclic
  LbrM31_V2.3260                                                        Nucleoporin (NUP54/57)          1.50    0.0266    SRR    Metacyclic
  LbrM04_V2.0550                                                           Unknown function             1.53    0.0434    SRR    Metacyclic
  LbrM15_V2.0460/LbrM15_V2.0470/LbrM15_V2.0480                             Unknown function             1.55    0.0119           Metacyclic
  LbrM04_V2.0470[§](#nt103){ref-type="table-fn"}                           Unknown function             1.70    0.0090           Metacyclic
  LbrM21_V2.2150/LbrM33_V2.0920/LbrM33_V2.0930/LbrM33_V2.0960                Beta-tubulin               1.71    0.0059           Metacyclic
  LbrM18_V2.0050[§](#nt103){ref-type="table-fn"}                         Transporter (sugar)            1.95    0.0004           Metacyclic
  LbrM08_V2.0810/LbrM08_V2.0820/LbrM08_V2.0830                        Cathepsin L-like protease         1.95    0.0001    \*     Metacyclic
  LbrM27_V2.2760                                                         Peptidyl dipeptidase           1.97    0.0211           Metacyclic
  LbrM30_V2.1290                                                           Unknown function             2.03    0.0044           Metacyclic
  LbrM31_V2.3150                                                       Adp-ribosylation factor          2.08    0.0000   NMT\*   Metacyclic
  LbrM34_V2.0500                                                           Unknown function             2.15    0.0000           Metacyclic
  LbrM21_V2.0360                                                           Unknown function             2.25    0.0006    NMT    Metacyclic
  LbrM30_V2.2320                                                 Adp-ribosylation factor-like protein   2.28    0.0113           Metacyclic
  LbrM20_V2.0550                                                           Unknown function             2.48    0.0079   SRR\*   Metacyclic

  *L. braziliensis*: Procyclics vs Metacyclics                                                                       
  ------------------------------------------------ ------------------------------------------ ------- -------- ----- ------------
  LbrM04_V2.0370                                            Adp-ribosylation factor            −3.67   0.0016   NMT   Procyclic
  LbrM16_V2.0790                                                Unknown function               −3.08   0.0061         Procyclic
  LbrM31_V2.0450                                                Unknown function               −3.08   0.0078         Procyclic
  LbrM05_V2.0960                                                Unknown function               −2.77   0.0171         Procyclic
  LbrM31_V2.1250                                                Unknown function               −2.50   0.0223   SRR   Procyclic
  LbrM15_V2.0940                                                Unknown function               −2.42   0.0180   SRR   Procyclic
  LbrM34_V2.0010/LbrM34_V2.0040/LbrM34_V2.0060                  Pyruvate kinase                −2.35   0.0444         Procyclic
  LbrM32_V2.3450                                                Unknown function               −2.17   0.0356         Procyclic
  LbrM30_V2.1290                                                Unknown function               −1.95   0.0304         Procyclic
  LbrM07_V2.0950                                                Unknown function               −1.91   0.0389         Procyclic
  LbrM32_V2.2500                                    Membrane associated protein-like protein   0.79    0.0223   SRR   Metacyclic
  LbrM19_V2.1010                                                    Kinesin                    0.83    0.0039   SRR   Metacyclic
  LbrM29_V2.0470                                                Unknown function               1.31    0.0383   SRR   Metacyclic
  LbrM18_V2.1250                                                Unknown function               1.55    0.0306   NMT   Metacyclic
  LbrM18_V2.0050[§](#nt103){ref-type="table-fn"}              Transporter (sugar)              1.62    0.0169         Metacyclic
  LbrM08_V2.0810/LbrM08_V2.0820/LbrM08_V2.0830             Cathepsin L-like protease           1.67    0.0064         Metacyclic
  LbrM20_V2.1060                                          Amastin-like surface protein         2.02    0.0257         Metacyclic
  LbrM20_V2.0610                                                Unknown function               2.05    0.0134   SSR   Metacyclic
  LbrM30_V2.2950                                    Glyceraldehyde 3-phosphate dehydrogenase   2.12    0.0359         Metacyclic
  LbrM20_V2.0550                                                Unknown function               2.46    0.0378   SRR   Metacyclic
  LbrM12_V2.0750                                       Surface antigen proteins (1 and 2)      3.08    0.0000   SRR   Metacyclic
  LbrM34_V2.4130                                             Poly A binding protein            3.47    0.0021   SRR   Metacyclic

**GeneDB ID**, gene accession number on GeneDB (<http://www.genedb.org/>); **Product**, predicted gene function (annotation from GeneDB); **LogFC**, log~2~ fold change observed between compared RNAs in array studies; **P value**, measure of statistical significance (p\<0.05 is statistically significant); **Note**, indicates whether gene is from a specific subset (SSR -- amino acid repeat containing gene, NMT -- target for *N*-myristoylation); \* indicates where array data are validated by qPCR (see [Table 4](#pntd-0000476-t004){ref-type="table"}); **Up in**, indicates species or lifecycle stage with increased expression of target gene.

**§:** annotated as a pseudogene in GeneDB.

Cross species comparison of amastigote RNA expression {#s3b}
-----------------------------------------------------

Pair-wise comparisons of amastigote RNA profiles for each of the three species identified only a small number of conserved genes showing differential expression. Varying numbers of probes were directly comparable between the species (as some genes are present in two rather than three species) including 608 between *L. braziliensis* and *L. major*, 615 between *L. braziliensis* and *L. infantum* and 686 between *L. major* and *L. infantum*. The expression profiles are shown in [Figure 1D--F](#pntd-0000476-g001){ref-type="fig"}, with the number of differentially expressed genes in each species summarised in [Figure 3](#pntd-0000476-g003){ref-type="fig"} (with details in [Table S4](#pntd.0000476.s004){ref-type="supplementary-material"}). These analyses were used to identify genes showing significantly increased amastigote expression in one species compared with the other two ([Table 3](#pntd-0000476-t003){ref-type="table"}). Five genes were identified as showing significantly increased expression in *L. braziliensis* amastigotes: 2 genes with predicted functions (LbrM08_V2.0810 - cathepsin L-like protease, LbrM25_V2.1020 and LbrM35_V2.3370 - ADP-ribosylation factor) and 3 genes of unknown function (LbrM06_V2.0730, LbrM20_V2.0550 and LbrM21_V2.0910). A further 5 genes showed significantly increased expression in *L. major* amastigotes, 4 of which code for proteins of predicted functions (LmjF06.0400 - Fructose biphosphate aldolase, LmjF24.1730 - protein kinase, LmjF31.0830 - Triacyglycerol lipase, LmjF36.5370- tyrosine specific protein phosphatase) while the last codes for an unknown protein (LmjF31.1400). A total of 15 genes showed significantly increased expression in *L. infantum* amastigotes alone, including 10 coding for proteins of unknown function (LinJ05_V3.0670, LinJ07_V3.0270, LinJ07_V3.0950, LinJ10_V3.1230, LinJ13_V3.0770, LinJ14_V3.0470, LinJ18_V3.1160, LinJ24_V3.1530, LinJ29_V3.0110 and LinJ31_V3.1470). and 5 for proteins of predicted function (LinJ12_v4.0671 -- surface antigen protein, LinJ04_V3.0320 - mitochondrial exoribonuclease DSS-1, LinJ11_V3.0400 - tubulin-tyrosine ligase-like protein, LinJ31_V3.1490 - surface membrane protein gp46-like protein and the proteophosphoglycan ppg3 array on chromosome 35 (chromosome 34 in *L. braziliensis*). Interestingly, gp46 has also been identified as an upregulated gene in *L. donovani* amastigotes derived from patients with PKDL (post-kala azar dermal leishmaniasis; [@pntd.0000476-Salotra1]).

![Differential expression of amastigote genes between *Leishmania* species.\
Venn diagrams showing pairwise comparisons of amastigote RNA expression from the three target *Leishmania* species; the number of genes with increased expression (\>1.7-fold, p\<0.05) in each species is indicated. \*Genes that show no significant difference in expression between species.](pntd.0000476.g003){#pntd-0000476-g003}
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###### Conserved genes preferentially expressed in amastigotes.

![](pntd.0000476.t003){#pntd-0000476-t003-3}

  Genes preferentially expressed in *L. braziliensis* amastigotes                                                                                                
  ----------------------------------------------------------------- ---------------- ---------------- --------------------------------------------------- ------ ------
  LmjF34.0620                                                        LinJ34_V3.0640   LbrM20_V2.0550                   Unknown function                    2.12   2.33
  LmjF08.1020                                                        LinJ08_V3.0960   LbrM08_V2.0810               Cathepsin L-like protease               1.58   1.49
  LmjF06.0740                                                        LinJ06_V3.0770   LbrM06_V2.0730                   Unknown function                    1.00   1.45
  LmjF36.3150                                                        LinJ36_V3.3300   LbrM35_V2.3370   Adp-ribosylation factor GTPase activating protein   0.98   0.79
  LmjF21.0820                                                        LinJ21_V3.0900   LbrM21_V2.0910                   Unknown function                    0.92   0.95

  Genes preferentially expressed in *L. infantum* amastigotes                                                                                                                      
  ------------------------------------------------------------- ---------------- ------------------------------------------------ ----------------------------------------- ------ ------
  LmjF03.0230                                                    LinJ03_V3.0220                   LbrM03_V2.0240                    Long chain fatty Acyl CoA synthetase     2.41   2.30
  LmjF04.0330                                                    LinJ04_V3.0320                   LbrM04_V2.0360                     Mitochondrial exoribonuclease DSS-1     1.19   1.99
  LmjF05.0670                                                    LinJ05_V3.0670                   LbrM05_V2.0660                              Unknown function               2.46   2.34
  LmjF07.0120                                                    LinJ07_V3.0270                   LbrM07_V2.0120                              Unknown function               1.74   1.55
  LmjF07.0840                                                    LinJ07_V3.0950                   LbrM07_V2.0890                              Unknown function               2.21   0.80
  LmjF10.1140                                                    LinJ10_V3.1230                   LbrM10_V2.1250                              Unknown function               2.10   2.73
  LmjF11.0400                                                    LinJ11_V3.0400                   LbrM11_V2.0080                    Tubulin-tyrosine ligase-like protein     1.11   1.01
  LmjF13.0880                                                    LinJ13_V3.0770                   LbrM13_V2.0690                              Unknown function               1.82   1.64
  LmjF14.0470[§](#nt104){ref-type="table-fn"}                    LinJ14_V3.0470                   LbrM14_V2.0480                              Unknown function               0.85   0.86
  LmjF18.1150                                                    LinJ18_V3.1160                   LbrM18_V2.1250                              Unknown function               1.27   0.77
  LmjF22.1680[§](#nt104){ref-type="table-fn"}                    LinJ22_V3.1530   LbrM22_V2.1590[§](#nt104){ref-type="table-fn"}   Phosphoinositide-specific phosphatase C   0.98   0.86
  LmjF24.1470                                                    LinJ24_V3.1530                   LbrM24_V2.1380                              Unknown function               2.58   2.70
  LmjF29.0110                                                    LinJ29_V3.0110                   LbrM29_V2.0120                              Unknown function               1.27   0.95
  LmjF31.1440                                                    LinJ31_V3.1470                   LbrM31_V2.1670                              Unknown function               1.30   1.26
  LmjF31.1440                                                    LinJ31_V3.1470                   LbrM31_V2.1670                              Unknown function               2.13   2.52
  LmjF35.0520                                                    LinJ35_V3.0530                   LbrM34_V2.0520                     Proteophosphoglycan ppg3, putative      1.53   1.24

  Genes preferentially expressed in *L. major* amastigotes                                                                                                                                                 
  ---------------------------------------------------------- --------------------------------------------- ------------------------------------------------ --------------------------------------- ------ ------
  LmjF06.0400[§](#nt104){ref-type="table-fn"}                 LinJ06.0400[§](#nt104){ref-type="table-fn"}   LbrM06_V2.0380[§](#nt104){ref-type="table-fn"}       Fructose biphosphate aldolase       1.08   0.81
  LmjF24.1730                                                               LinJ24_V3.1800                                  LbrM24_V2.1790                         Protein kinase, putative          1.15   1.15
  LmjF31.0830                                                               LinJ31_V3.0860                  LbrM31_V2.1010[§](#nt104){ref-type="table-fn"}           Triacyglycerol lipase           0.78   0.79
  LmjF31.1400                                                               LinJ31_V3.1430                                  LbrM31_V2.1560                             Unknown function              1.44   0.80
  LmjF36.5370                                                               LinJ36_V3.5610                                  LbrM35_V2.5630                   Tyrosine specific protein phosphatase   1.50   0.77

**ID**, gene accession number on GeneDB (<http://www.genedb.org/>); **Product**, predicted gene function (GeneDB annotation); **LogFC**, log~2~ fold change observed between compared RNAs in array studies. Lb, *L. braziliensis*; Lm, *L. major*; Li, *L. infantum*.

**§:** annotated as pseudogene.

The ppg3 gene is located within an array of related sequences (still undergoing refinement of annotation due to their repetitive structure) on chromosome 35 of *Leishmania* species and codes for one of the glycoprotein constituents of filamentous proteophosphoglycan (fPPG), a major component of promastigote secretory gel (PSG). PSG is produced by parasites within the gut of the sandfly vector, where it contributes to a physical blockage that promotes host blood-feeding and subsequent parasite transmission [@pntd.0000476-Rogers1],[@pntd.0000476-Bates1]. The *Leishmania* PPGs belong to a novel class of serine- and threonine-rich proteins possessing large conserved Ala-Pro-Ser repeats that represent major antigenic determinants in all *Leishmania* species examined to date [@pntd.0000476-Rogers1],[@pntd.0000476-Montgomery1],[@pntd.0000476-Samant1]. These repeats are extensively modified by phosphodiester-linked oligosaccharides and terminal manno-oligosaccharides, while the modified PPGs are either water soluble and secreted or membrane-bound. PPGs are expressed in both promastigotes and amastigotes, localising to the flagellar pocket, endosomes, lysosomes and the external surface of the parasite [@pntd.0000476-Ilg1],[@pntd.0000476-Ilg2],[@pntd.0000476-Foth1]. Surface PPGs are important in parasite-macrophage interactions: they apparently bind to host cells to modulate macrophage function during early infection, both by inhibiting tumor necrosis factor-α production and synergizing with interferon-γ to stimulate the production of nitric oxide [@pntd.0000476-Piani1]. The significance of increased RNA expression from the PPG gene array in *L. infantum* amastigotes (as compared with *L. major* and *L. braziliensis* amastigotes) is unknown; no studies have yet investigated the *L. infantum* PPGs or addressed whether one or more of these molecules might perform a species-specific role in establishing and maintaining amastigotes within host macrophages.

Calmodulin, the ubiquitous eukaryotic intracellular calcium receptor, plays a role in the regulation of many cellular proteins and transmembrane ion transporters with wide-ranging downstream physiological consequences. Calmodulin is encoded by a 3-gene array on chromosome 9 in *Leishmania* but has not yet been widely studied in this organism, despite linkage to the modulation of a plasma membrane Ca^2+^-ATPase in *L. donovani* [@pntd.0000476-Mazumder1]. In this present study, both the array analyses and subsequent RT-qPCRs show decreased abundance of calmodulin transcripts in amastigotes of *L. major* and *L. infantum* as compared with procyclic and metacyclic parasites. This correlates with the observed changes in calmodulin protein during *in vitro* differentiation of *L. donovani* [@pntd.0000476-Rosenzwieg1]. By contrast, calmodulin transcript levels are upregulated in *L. braziliensis* amastigotes ([Figure 4](#pntd-0000476-g004){ref-type="fig"}). To date, it is unclear whether these RNA differences reflect mRNAs derived from one or several of the gene copies, nor how this distribution might vary between the species. It is also unknown whether the varying RNA levels correlate with protein expression in *L. braziliensis* and how this might influence calmodulin function in different amastigote populations.

![Calmodulin RNA expression is upregulated in amastigotes of *L. braziliensis*.\
Comparison of amastigote RNA levels by both microarray and RT-qPCR analysis demonstrates increased expression from the chromosome 9 calmodulin gene array in *L. braziliensis* but decreased expression in *L. major* and *L. infantum*. 2 independent biological replicates were used to generate data from each species.](pntd.0000476.g004){#pntd-0000476-g004}

Genes differentially distributed between the three representative *Leishmania* species are usually constitutively expressed {#s3c}
---------------------------------------------------------------------------------------------------------------------------

The small number of differentially distributed genes identified by comparative genomic analysis of *L. major*, *L. infantum* and *L. braziliensis* [@pntd.0000476-Murray1] include several well-characterised stage specific genes that are implicated in vector transmission and virulence in the host (e.g. A2, HASPB, SHERP [@pntd.0000476-Zhang1],[@pntd.0000476-Knuepfer1],[@pntd.0000476-McKean2]. The expression profiles for the ∼200 differentially distributed genes were determined from the *L. braziliensis* life cycle analysis generated here and supplemented with published microarray data generated from life cycle studies of *L. major* and *L. infantum* [@pntd.0000476-Holzer1],[@pntd.0000476-Rochette1] ([Table S1](#pntd.0000476.s001){ref-type="supplementary-material"}). These cumulative results have confirmed that all genes differentially distributed between the three species are expressed in all life cycle stages. Only 34 of these sequences are regulated between stages, however: 19 in *L. major*, 9 in *L. infantum* and 6 in *L. braziliensis*. The majority of these genes encode proteins of unknown function while the remainder are the HASPA, HASPB and SHERP genes from *L. Leishmania* species as well as an adenine phosphoribosyltransferase (LbrM26_V2.0120) and a unique gene family in *L. braziliensis* (LbrM23_V2.1110 and LbrM23_V2.1120) and the *L. infantum* specific LinJ22_V3.0670.

*Leishmania* transcriptomes undergo little regulation but the conserved genes that are regulated vary between species {#s3d}
---------------------------------------------------------------------------------------------------------------------

Previous comparisons of the life cycle expression profiles of *L. major*, *L. infantum* and *L. mexicana* have revealed similar numbers of genes that are regulated during the life cycle [@pntd.0000476-Holzer1],[@pntd.0000476-Leifso1],[@pntd.0000476-Rochette1]. The most interesting observation associated with these data is that, while these regulated genes are conserved between all three species, whether they are regulated or not appears to be a species-specific property. As an example of this, only 114/1228 of the conserved regulated genes of *L. major* and *L. infantum* undergo modulation in both species [@pntd.0000476-Rochette1]. A similar effect has been observed in comparisons between *L. major* and *L. mexicana* promastigote RNA expression profiles [@pntd.0000476-Holzer1]. In this current study, of the 21 genes identified as being stage regulated in *L. braziliensis* ([Table S5](#pntd.0000476.s005){ref-type="supplementary-material"}), 14 are only regulated in this species while 6 share regulation with either *L. major* or *L. infantum* and one, a 3′-nucleotidase/nuclease, is regulated in all three species and shows upregulation in amastigotes [@pntd.0000476-Holzer1],[@pntd.0000476-Rochette1]. *Leishmania* parasites are purine auxotrophs and require mechanisms to salvage these essential nutrients from the sandfly gut and the host [@pntd.0000476-Hammond1],[@pntd.0000476-Hassan1],[@pntd.0000476-Steiger1]. The 3′-nucleotidase/nuclease [@pntd.0000476-Gottlieb1] degrades and dephosphorylates exogenous purine sources to nucleosides that can be transported across the plasma membrane [@pntd.0000476-Gottlieb1]. Independent studies in *L. donovani* [@pntd.0000476-Debrabant1] and *L. mexicana* [@pntd.0000476-Sopwith1] have shown that 3′-nucleotidase/nuclease mRNA transcripts are upregulated in promastigotes when parasites are starved of purines but not in amastigotes. One interpretation of these conflicting observations could be that there are additional gene copies expressing nucleotidase/nuclease activity during the parasite life cycle. The complete list of all regulated genes identified in *L. braziliensis*, *L. major* and *L. infantum* is presented in [Table S5](#pntd.0000476.s005){ref-type="supplementary-material"}.

Host immune pressure reduces parasite dissemination and survival in the viscera but does not influence parasite RNA expression profiles {#s3e}
---------------------------------------------------------------------------------------------------------------------------------------

The influence of host immune pressure on gene expression in *Leishmania* has not been studied *in vivo* to our knowledge. In this study, parasite burdens, lesion development, and parasite gene expression profiles were examined in immunocompetent BALB/c and immunocompromised Rag2^−/−^γ~c~ ^−/−^ mice which have a mixed genetic background of 129 Ola, BALB/c and C57BL/6 [@pntd.0000476-Goldman1]. These latter mice possess a mutation in the common γ-chain receptor (a component of the receptors for IL-2, -4, -7, -9 and -15) and in the recombination activating gene 2 (Rag2; required for V(J)D rearrangement) and are characterised by a complete absence of mature T lymphocytes, B lymphocytes and NK cells [@pntd.0000476-Goldman1].

Footpad infections were established by inoculation with 4×10^6^ metacyclic *L. major* parasites and resultant lesion formation was measured at weekly intervals. The Rag2^−/−^γ~c~ ^−/−^ mice displayed no signs of inflammation in the footpad and did not develop cutaneous lesions. In contrast, vigorous lesion development was seen in BALB/c mice with a greater than 2-fold increase in footpad thickness at one month post-infection ([Figure 5A](#pntd-0000476-g005){ref-type="fig"}). Parasite burdens in the footpads of Rag2^−/−^γ~c~ ^−/−^ mice were significantly lower than in the BALB/c mice; however these immunocompromised mice showed 2.5-fold higher parasite burdens in the liver and spleen ([Figure 5B--D](#pntd-0000476-g005){ref-type="fig"}). Enhanced parasite burdens in visceral organs may arise from accelerated dissemination of parasites through the lymphatic system from the site of infection, as Rag2^−/−^γ~c~ ^−/−^ mice lack peripheral lymph nodes. In addition, survival and proliferation of parasites may be increased in these tissues due to the inability of Rag2^−/−^γ~c~ ^−/−^ mice to mount protective T and B cell dependant responses required for parasite clearance.

![Comparison of *L. major* infections in BALB/c and Rag2^−/−^γ~c~ ^−/−^ mice.\
Groups of 5 mice of each strain were inoculated with *L. major* purified metacyclics and infections monitored over a 4 week period as described ([Materials and Methods](#s2){ref-type="sec"}). (A) Lesion development (footpad thickness); (B) parasite burdens in footpad lesions after 4 weeks; (C) parasite burdens in spleen after 4 weeks; (D) parasite burdens in liver after 4 weeks. The data presented are representative of two independent studies; error bars represent the standard error of the mean and the \* indicates a significant difference (p\<0.05) as determined by Students t-test (unpaired).](pntd.0000476.g005){#pntd-0000476-g005}

Expression profiling of the amastigotes taken from the footpads of these mouse strains revealed only 3 genes that showed a significant difference in expression (out of 700 genes on the array). Only one of these genes (LmjF06.0720, coding for a protein of unknown function) was preferentially expressed in amastigotes from BALB/c mice. The other 2 genes showed increased expression in the Rag2^−/−^γ~c~ ^−/−^ mice: LmjF24.1840, a lysophospholipase and LmjF35.4730, another "unknown" gene ([Table 4](#pntd-0000476-t004){ref-type="table"}). Independent analysis of HASPB transcript and protein abundance in these amastigotes (by RT-qPCR and immunoblotting respectively) revealed no significant differences in expression ([Figure 6](#pntd-0000476-g006){ref-type="fig"}). This lack of amastigote RNA modulation, assuming that it correlates with protein expression levels, confirms that *Leishmania* parasites are pre-adapted toward intracellular survival, regardless of the state of the host immune system. These data are of relevance to our interpretation of the cross-species amastigote expression results ([Table 3](#pntd-0000476-t003){ref-type="table"}) given that the amastigotes were sourced from rodents of different genetic backgrounds.

![HASPB RNA and protein abundance in *L. major* amastigotes isolated from BALB/c and Rag2^−/−^γ~c~ ^−/−^ mice.\
Amastigotes isolated from the livers of two mice of each strain (BALB/c and Rag2^−/−^γ~c~ ^−/−^ mice), 4 weeks post-infection with *L. major* (see [Figure 5](#pntd-0000476-g005){ref-type="fig"}), were used for RNA and protein extraction, as described. HASPB expression was analysed by (A) RT-qPCR for RNA and (B) immunoblotting with anti-HASPB for protein (*L. major* HASPB migrates at 38.5 kDa (black arrow); NMT, at 50 kDa (white arrow)). NMT was used as a constitutive control for both RNA and protein expression levels.](pntd.0000476.g006){#pntd-0000476-g006}

10.1371/journal.pntd.0000476.t004

###### Genes differentially expressed in *L. major* amastigotes from different host genetic backgrounds.

![](pntd.0000476.t004){#pntd-0000476-t004-4}

  GeneDB ID                                           Product        LogFC   P.Value   Note                 Up in
  --------------------------------------------- ------------------- ------- --------- ------- ---------------------------------
  LmjF06.0720                                    Unknown function    −0.95   0.0091    SRR\*         Balb/c amastigotes
  LmjF24.1840                                    Lysophospholipase   1.35    0.0000     \*     Rag2^−/−^γ~c~ ^−/−^ amastigotes
  LmjF35.4730[§](#nt105){ref-type="table-fn"}    Unknown function    0.82    0.0003     \*     Rag2^−/−^γ~c~ ^−/−^ amastigotes

**GeneDB ID**, gene accession number on GeneDB (<http://www.genedb.org/>); **Product**, predicted gene function (annotation from GeneDB); **LogFC**, log~2~ fold change observed between compared RNAs in array studies; **P value**, measure of statistical significance; **Note**, indicates whether gene is from a specific subset (SSR -- amino acid repeat containing gene, NMT -- target for *N*-myristoylation); \*indicates where array data are validated by qPCR (see [Table 4](#pntd-0000476-t004){ref-type="table"}); **Up in**, indicates host with increased expression of target gene.

**§:** annotated as a pseudogene in GeneDB.

Concluding remarks {#s3f}
------------------

Small microarrays, targeted towards 9% of the genes conserved between the three representative *Leishmania* species and an additional ∼250 genes differentially distributed between these species, were designed and hybridised with host-derived amastigote RNA isolated from cutaneous lesions (*L. major*), spleens (*L. infantum*) and RAW 264.7 macrophages (*L. braziliensis*). ∼9% of the probed genes were identified as being regulated during the *L. braziliensis* life cycle, a figure comparable to that observed using whole genome arrays for *L. major*, *L. mexicana* and *L. infantum* [@pntd.0000476-Holzer1],[@pntd.0000476-Rochette1]. It is interesting to note however, that while most regulated genes are conserved between all three representative species, the majority of genes regulated in one species are not regulated in the others. Moreover, comparative expression profiles generated for *L. major*, *L. infantum* and *L. braziliensis* amastigotes revealed that species-specific differential regulation of conserved genes was common and this may impact on parasite survival in the host. These species-specific differences require further study that should focus on determining whether relative protein abundances are affected by increased transcript abundances. Attempts to correlate the relative abundance of mRNA and protein for individual genes in *L. infantum* amastigotes resulted in only modest agreement (∼53% [@pntd.0000476-McNicoll1]), with these differences attributed to the extensive post-transcriptional, translational and post-translational regulation operating in *Leishmania* parasites [@pntd.0000476-Leifso1],[@pntd.0000476-McNicoll1]. Finally, the lack of modulation of gene expression profiles in *L. major* parasites responding to different immune pressures is consistent with the hypothesis that *Leishmania* parasites are constitutively adapted toward survival in a range of hosts [@pntd.0000476-CohenFreue1].
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List of genes differentially distributed between three *Leishmania* species with microarray analysis derived from this study or ref [@pntd.0000476-Rochette1].

(0.06 MB XLS)
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Click here for additional data file.
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All 70-mer oligonucleotides used in the microarray studies reported in Depledge et al., 2009.

(0.13 MB XLS)
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Click here for additional data file.
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List of primers used in qPCR validation of microarray data.
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Genes differentially expressed between amastigotes of three *Leishmania* species.
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*Leishmania* genes demonstrating stage regulation in one or more species.

(0.14 MB PDF)
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Click here for additional data file.
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